PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma.
Employing Northern blot analysis and the polymerase chain reaction, we investigated PRAD1 gene overexpression in the tumour tissues of 58 patients with B-cell lymphoma. These findings were then examined in relation to the patients' clinical and immunohistological characteristics. The over-expression of this gene was detected in 6/8 patients with mantle cell lymphoma (MCL) and in only 1/50 other lymphomas, indicating its close association with MCL. The patients with MCL had common clinical findings of advanced disease with generalized lymphadenopathy on admission, and they had a CD5+CD10-IgD+ phenotype. The patients with chronic lymphocytic leukaemia (CLL) also showed findings indicating a distinctive disease entity: a CD5+CD10-IgD+ phenotype and lack of PRAD1 over-expression. In contrast, most patients with diffuse low-grade lymphoma other than MCL and CLL had localized extranodal disease, expressed a CD5-CD10-IgD- phenotype, and lacked PRAD1 over-expression. These findings suggest that extranodal low-grade lymphomas differ from nodal MCL and are not part of the spectrum of CLL.
Oka
K
K
Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan.
Ohno
T
T
Kita
K
K
Yamaguchi
M
M
Takakura
N
N
Nishii
K
K
Miwa
H
H
Shirakawa
S
S
D001483:Base Sequence; D015152:Blotting, Northern; D019938:Cyclin D1; D016213:Cyclins / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology; D016393:Lymphoma, B-Cell / Q000235:genetics; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics* / Q000473:pathology; D008969:Molecular Sequence Data; D015513:Oncogene Proteins / Q000235:genetics*; D016133:Polymerase Chain Reaction
D016213:Cyclins; D015513:Oncogene Proteins; D019938:Cyclin D1